Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04204616
Recruitment Status : Not yet recruiting
First Posted : December 19, 2019
Last Update Posted : August 5, 2020
Sponsor:
Information provided by (Responsible Party):
Galderma R&D

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : August 5, 2022
Estimated Study Completion Date : September 30, 2022